ORTHOPAEDIC FELLOWSHIP FACULTY

Przemysław LubiatowskiMedical Director and Board Member · Rehasport / Poznań University of Medical Sciences

Shoulder, elbow, hand and wrist surgery; sports biomechanics

EDITORIAL SUMMARY

About Przemysław Lubiatowski

Rehasport identifies Professor Lubiatowski as its medical director, head of a sports-traumatology and biomechanics laboratory and a former leader of Polish shoulder-and-elbow societies. The source identifies Przemysław Lubiatowski as Medical Director and Board Member at Rehasport / Poznań University of Medical Sciences. The published clinical or academic focus includes Shoulder, elbow, hand and wrist surgery; sports biomechanics. Published qualifications include MD, PhD, Professor.

Within OrthoFellow, Przemysław Lubiatowski is connected to 1 current programme: Comprehensive Orthopaedic Fellowship. These links come from named faculty or programme-lead associations in the cited programme records; they are not inferred from specialty, publication history or geographic proximity.

The associated opportunities span Sports Medicine across Poland, with observership represented. Applicants should open each programme profile separately because faculty involvement does not by itself confirm a current application window, clinical privileges, funding, eligibility or direct supervision for a future intake.

This editorial page summarises source-backed professional and programme relationships already published in OrthoFellow. It does not reproduce an institutional biography or claim endorsement by Przemysław Lubiatowski. The official individual profile remains the primary source for current appointments and credentials, while each linked programme profile records its own evidence, status and verification date.

Appointments and faculty rosters can change. The official individual profile and programme source remain authoritative.

PROGRAMME CONNECTIONS

Fellowships and training associated with Przemysław Lubiatowski

Each programme keeps its own application status, deadline, eligibility, funding and evidence trail.